REILLY MUNSON: Open Payments
NPI 1225899610 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 15 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $603 · 2025 $442
Food & beverage: $364Education: $78
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 1 | $78 |
| Smith+Nephew, Inc. | 2 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Averitas Pharma Inc. | 1 | $37 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| GENZYME CORPORATION | 1 | $28 |
| Rigel Pharmaceuticals, Inc. | 1 | $27 |
| Deciphera Pharmaceuticals Inc. | 1 | $25 |
| Genmab U.S., Inc. | 1 | $23 |
| Karyopharm Therapeutics Inc. | 1 | $22 |
Products named: GRAFIX, Nubeqa, QUTENZA, AYVAKIT, TAVALISSE, QINLOCK, Epkinly, XPOVIO.
Industry payments across TN — which companies pay providers there.
